GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Institutional Ownership

Stealth BioTherapeutics (Stealth BioTherapeutics) Institutional Ownership : 0.07% (As of May. 26, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Stealth BioTherapeutics's institutional ownership is 0.07%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Stealth BioTherapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Stealth BioTherapeutics's Float Percentage Of Total Shares Outstanding is 0.00%.


Stealth BioTherapeutics Institutional Ownership Historical Data

The historical data trend for Stealth BioTherapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Institutional Ownership Chart

Stealth BioTherapeutics Historical Data

The historical data trend for Stealth BioTherapeutics can be seen below:

2022-01-31 2022-02-28 2022-03-31 2022-04-30 2022-05-31 2022-06-30 2022-07-31 2022-08-31 2022-09-30 2022-10-31
Institutional Ownership 0.05 0.05 0.10 0.10 0.08 0.08 0.08 0.08 0.07 0.07

Stealth BioTherapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Traded in Other Exchanges
N/A
Address
c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005
Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.

Stealth BioTherapeutics (Stealth BioTherapeutics) Headlines

From GuruFocus

Stealth BioTherapeutics Corp Announces Completion of Merger

By PRNewswire PRNewswire 11-16-2022